TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 13 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $20,231,000 | -8.8% | 1,111,580 | -10.6% | 0.06% | -20.0% |
| Q3 2020 | $22,189,000 | +20.1% | 1,243,782 | +20.7% | 0.08% | +10.3% |
| Q2 2020 | $18,476,000 | +62.2% | 1,030,442 | +37.3% | 0.07% | +36.0% |
| Q1 2020 | $11,393,000 | -43.1% | 750,544 | -26.1% | 0.05% | -30.6% |
| Q4 2019 | $20,031,000 | +40.8% | 1,015,231 | +22.7% | 0.07% | +28.6% |
| Q3 2019 | $14,229,000 | +34.4% | 827,273 | +38.3% | 0.06% | +30.2% |
| Q2 2019 | $10,584,000 | -41.1% | 597,964 | -32.2% | 0.04% | -44.9% |
| Q1 2019 | $17,975,000 | +346.8% | 882,411 | +268.9% | 0.08% | +290.0% |
| Q4 2018 | $4,023,000 | -41.7% | 239,187 | -17.6% | 0.02% | -79.4% |
| Q1 2014 | $6,895,000 | +6.6% | 290,284 | +3.0% | 0.10% | -3.0% |
| Q4 2013 | $6,470,000 | +16.6% | 281,882 | +19.9% | 0.10% | -6.5% |
| Q3 2013 | $5,551,000 | +20.3% | 235,055 | +14.8% | 0.11% | -2.7% |
| Q2 2013 | $4,615,000 | – | 204,669 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |